Skip to main content

Want a detailed portfolio tracker?

Natera (NTRA) Market Cap (2015 - 2026)

Natera (NTRA) market cap from Jul 2, 2015 to Jul 20, 2026. The current Natera (NTRA) market cap is $37B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Natera (NTRA) Market Cap CAGR table

PeriodCAGR
1 Year TTM+51.22%
3 Years TTM+78.68%
5 Years TTM+29.51%
10 Years TTM+51.83%
All Time TTM+52.22%

Annual Market Cap change of Natera (NTRA)

YearMarket CapChange
2026$37B+17.14%
2025$32B+52.41%
2024$21B+181.72%
2023$7.45B+90.70%
2022$3.91B-56.01%
2021$8.89B+3.55%
2020$8.58B+226.52%
2019$2.63B+203.23%
2018$867M+79.50%
2017$483M-20.72%
2016$609M+12.90%
2015$539MN/A

Comparison Natera (NTRA) market cap with competitors

Natera (NTRA) market cap is $37.49B.

TickerNameMarket CapUpside
TMOThermo Fisher Scientific Inc$199.13B+431.20%
DHRDanaher Corp$142.10B+279.07%
IDXXIdexx Laboratories Inc$44.14B+17.75%
AAgilent Technologies Inc$38.03B+1.44%
WATWaters Corp$36.80B-1.82%
IQVIQVIA Holdings Inc$34.52B-7.91%
ILMNIllumina Inc$28.63B-23.61%
MTDMettler-Toledo International Inc$28.12B-24.99%
LHLaboratory Corp Of America Holdings$22.39B-40.28%
DGXQuest Diagnostics Inc$22.19B-40.79%
GHGuardant Health Inc$21.43B-42.83%
EXASExact Sciences Corp$20.02B-46.60%
MEDPMedpace Holdings Inc$15.11B-59.68%
ICLRIcon Plc$13.18B-64.85%
RVTYRevvity Inc$12.43B-66.84%
CRLCharles River Laboratories International Inc$10.99B-70.67%
QGENQiagen NV$8.51B-77.30%
BLLNBilliontoone Inc - Class A$5.97B-84.09%
TWSTTwist Bioscience Corp$5.76B-84.64%
SHCSotera Health Company$5.17B-86.21%
RDNTRadnet Inc$4.82B-87.13%
VCYTVeracyte Inc$4.75B-87.33%
ADPTAdaptive Biotechnologies Corp$3.66B-90.24%
OLKOlink Holding AB (publ)$3.24B-91.35%
GRALGRAIL Inc$3.06B-91.84%
WGSGeneDx Holdings Corp - Class A$1.96B-94.77%
PSNLPersonalis Inc$1.65B-95.59%
CDNACaredx Inc$1.53B-95.93%
OPKOpko Health Inc$910.65M-97.57%
CSTLCastle Biosciences Inc$727.71M-98.06%
FLGTFulgent Genetics Inc$606.16M-98.38%
MYGNMyriad Genetics Inc$595.66M-98.41%
NEONeogenomics Inc$251.93M-99.33%
BDSXBiodesix Inc$212.25M-99.43%
IMDXInsight Molecular Diagnostics Inc$155.62M-99.58%
FONRFonar Corp$131.05M-99.65%
XGNExagen Inc$103.58M-99.72%
BNRBurning Rock Biotech Ltd$64.43M-99.83%
PRPOPrecipio Inc$45.02M-99.88%
MDXHMDxHealth SA$21.96M-99.94%
MYNZMainz Biomed N.V.$12.03M-99.97%
CHEKCheck-Cap Ltd$9.42M-99.97%
XWELXWELL Inc$8.56M-99.98%
ADVBAdvanced Biomed Inc$7.21M-99.98%
MBAICheckCap Ltd$7.09M-99.98%
NDRAENDRA Life Sciences Inc$6.96M-99.98%
BIAFBioAffinity Technologies Inc$3.25M-99.99%
APDNApplied Dna Sciences Inc$3.21M-99.99%
FRESFresh2 Group Limited$2.97M-99.99%
NOTVInotiv, Inc. Common Stock$1.74M-100.00%
ISPCiSpecimen Inc$1.23M-100.00%
PRPHProPhase Labs Inc$415412.05-100.00%